Genetic Testing
Bacterial Genome Reference Based Data Analysis Illumina
Research analysis of existing Illumina bacterial genome sequencing data against a reference. It does not test a patient or select antibiotic treatment.
About this service
This catalog entry describes reference-based analysis of bacterial genome sequencing data. It is a bioinformatics service, not the collection or testing of a clinical specimen and not the sequencing itself. The reference genome, read quality, pipeline and project determine what can be reported. A sequence-based finding does not by itself establish infection or phenotypic antibiotic susceptibility.
Service highlights
- Research analysis of supplied bacterial genome reads against a reference.
- Specific reference, pipeline and outputs require project confirmation.
- No clinical diagnosis or treatment guidance.
Who may consider it
- Microbial genomics research groups.
- Laboratories with existing bacterial sequencing data and a defined research question.
What to expect
Confirm accepted read files, organism/reference, analysis pipeline, any resistance-marker scope, controls and output format. Confirm whether separate sample testing or sequencing is offered, availability, turnaround and current quote. This listing describes data analysis only.
Scope and limitations
The scope is research analysis of supplied bacterial sequence data. It does not establish that a person has an infection, prove a resistance phenotype, replace culture or susceptibility testing, diagnose disease, or recommend antibiotics.
Frequently asked questions
What does this service analyze?
It analyzes existing bacterial genome sequencing reads against a reference; the organism, reference and pipeline must be agreed.
Does it test samples or determine antibiotic susceptibility?
No such service is established here. Sequence-based markers are not the same as clinical susceptibility testing or a treatment recommendation.
What should be confirmed before a project?
Confirm data format, organism/reference, deliverables, whether lab work is separate, availability, turnaround and quote.